Global Patient Services at Sheba Medical Center – Tel Hashomer I shared a post with linkedin:
“We are proud to share that Jacob Schacter One of Israel’s leading oncologists specializing in melanoma, Lifetime Achievement Award from Israeli Society of Clinical Oncology and Radiotherapy; He was recognized for his long-standing contributions to this field.
Professor Schachter’s major contributions include:
- establishment of Ella Lemelbaum Melanoma and Immunotherapy Institute in 2004
- Leading one of the world’s most advanced and innovative clinical and research programs for melanoma and skin cancer
- Plays a central role in designing and conducting pioneering clinical trials in melanoma
- Significant contribution to the development of new treatments, with a particular focus on immunotherapy
- Extensive publication track record, including dozens of peer-reviewed articles in leading international medical journals
- Presentation of major research results at major international scientific conferences
Through decades of leadership, research, and clinical innovation, Professor Schacter has profoundly shaped the field of melanoma treatment and continues to improve patient outcomes in Israel and around the world. ”
Micah Amram Director of Global Patient Services at Sheba Medical Center-Tel Hashomer shared this post. add:
“This recognition is particularly meaningful because of Jacob Schacter’s long-standing dedication to advancing melanoma research and patient care, and his contributions, including establishing the Ella Lemelbaum Institute for Melanoma and Immunotherapy at the Jasidman Cancer Center in Sheba.
We congratulate you on this prestigious honor and thank you for your longstanding commitment to advancing cancer treatment at Sheba Medical Center at Tel Hashomer. ”
See more featured articles Jacob Schacter.